1. Targeting CLEC12A with Chimeric Antigen Receptor T Cells Can Overcome the Chemotherapy Refractoriness of Leukemia Stem Cells 
Saad S. Kenderian, Marco Ruella, Olga Shestova, Michael Klichinsky, Miriam Kim, Craig Soderquist, Adam Bagg, Reshma Singh, Celeste Richardson, Regina Young, Carl H. June, Saar I. Gill 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S247-S248 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Treatment with chemotherapy results in a relative increase of CLEC12A+ cells in patient derived AML xenograft models, indicating resistance of CLEC12A+ cells to chemotherapy.
Biology of Blood and Marrow Transplantation  , S247-S248DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Induction chemotherapy followed by CLL1-CARTs, but not by untransduced T cells results in eradication of leukemia (A) and prolonged survival in AML xenografts (B).
Biology of Blood and Marrow Transplantation  , S247-S248DOI: ( /j.bbmt )
Copyright © Terms and Conditions